Back
Blueprint Medicines Stock Price Chart

How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Buy
52
BPMC
Blueprint Medicines
Last Price:
$128.13
Seasonality Move:
11.22%
7 Day Trial
ALL ACCESS PASS
$
7

Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight selling pressure.
Blueprint Medicines Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 128.08 | Buy |
20-day SMA: | 118.35 | Buy |
50-day SMA: | 102.34 | Buy |
200-day SMA: | 95.74 | Buy |
8-day EMA: | 127.05 | Buy |
20-day EMA: | 120.04 | Buy |
50-day EMA: | 108.59 | Buy |
200-day EMA: | 97.88 | Buy |
Blueprint Medicines Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.03 | Buy |
Relative Strength Index (14 RSI): | 75.53 | Buy |
Chaikin Money Flow: | -1180116 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (100.99 - 128.61) | Buy |
Bollinger Bands (100): | (85.1 - 113.52) | Buy |
Blueprint Medicines Technical Analysis
Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Blueprint Medicines Stock
Is Blueprint Medicines Stock a Buy?
-
Blueprint Medicines share price is 128.12 while BPMC 8-day simple moving average is 128.08, which is a Buy signal.
-
The stock price of BPMC is 128.12 while Blueprint Medicines 20-day SMA is 118.35, which makes it a Buy.
-
Blueprint Medicines 50-day simple moving average is 102.34 while BPMC share price is 128.12, making it a Buy technically.
-
BPMC stock price is 128.12 and Blueprint Medicines 200-day simple moving average is 95.74, creating a Buy signal.
BPMC Technical Analysis vs Fundamental Analysis
Buy
52
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy or a Sell?
-
Blueprint Medicines stock is rated a BuyThe current Blueprint Medicines [BPMC] share price is $128.12. The Score for BPMC is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Blueprint Medicines Stock Info
Market Cap:
8.3B
Price in USD:
128.12
Share Volume:
3.5M
Blueprint Medicines 52-Week Range
52-Week High:
128.34
52-Week Low:
73.04
Buy
52
Blueprint Medicines (BPMC)
is a Buy
Blueprint Medicines Share Price Forecast
-
What is the Blueprint Medicines stock price today?The Blueprint Medicines stock price is 128.12 USD today.
-
Will BPMC stock go up or go down?Blueprint Medicines> share price is forecast to RISE/FALL based on technical indicators
-
Is Blueprint Medicines overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Blueprint Medicines is not overvalued.
Is Blueprint Medicines Stock a Buy?
-
Blueprint Medicines share price is 128.12 while BPMC 8-day exponential moving average is 127.05, which is a Buy signal.
-
The stock price of BPMC is 128.12 while Blueprint Medicines 20-day EMA is 120.04, which makes it a Buy.
-
Blueprint Medicines 50-day exponential moving average is 108.59 while BPMC share price is 128.12, making it a Buy technically.
-
BPMC stock price is 128.12 and Blueprint Medicines 200-day simple moving average is 97.88, creating a Buy signal.
Fundamental Analysis of Blueprint Medicines
Is Blueprint Medicines a good investment?
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.
Technical Analysis of Blueprint Medicines
Should I short Blueprint Medicines stock?
-
BPMC Moving Average Covergence Divergence (MACD) indicator is 8.03, suggesting Blueprint Medicines is a Buy
-
Blueprint Medicines Relative Strength Index (RSI) is 75.53, which suggest Blueprint Medicines is overbought
-
The Bollinger Bands (25) for Blueprint Medicines is (100.99 - 128.61), which suggest Blueprint Medicines is a Buy
-
The Bollinger Bands (100) for Blueprint Medicines is (85.1 - 113.52), which suggest Blueprint Medicines is a Buy
* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.